SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001493152-22-001640
Filing Date
2022-01-19
Accepted
2022-01-19 21:07:24
Documents
1
Period of Report
2021-12-09

Document Format Files

Seq Description Document Type Size
1 ownership.html 4/A  
1 ownership.xml 4/A 4179
  Complete submission text file 0001493152-22-001640.txt   5542
Mailing Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801 781-245-1325
Biofrontera Inc. (Issuer) CIK: 0001858685 (see all company filings)

IRS No.: 473765675 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOFONTERA INC., 120 PRESIDENTIAL WAY, SUITE 330 WOBURN MA 01801
Business Address
Monaco Erica L. (Reporting) CIK: 0001886200 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-40943 | Film No.: 22540451